On December 28, 2021, the JPO has Updated information on remedies based on "reasons of force majeure" and "good cause" when prescribed procedures are affected by COVID-19.
Details are as follows
Japan Patent Office
https://www.jpo.go.jp/e/news/koho/saigai/covid19_legitimate_reasons.html
The Maeda IP Newsletter explores the trends, analyzes the issues, and provides guidance on Japanese IP law and practice. Your subscription gets you email delivery of our current newsletter. Please submit the form below. We will send you an ID and a password for access to previous editions.
Subscribe the Email Newsletter
Location